These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 8809244

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The origin of informed consent].
    Mallardi V.
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].
    Zimmerer T, Siegmund SV, Singer MV.
    Dtsch Med Wochenschr; 2009 Jul; 134(27):1417-24. PubMed ID: 19551607
    [Abstract] [Full Text] [Related]

  • 29. Review article: improving adherence to medication in patients with inflammatory bowel disease.
    Robinson A.
    Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():9-14. PubMed ID: 18307644
    [Abstract] [Full Text] [Related]

  • 30. The network: a strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel disease.
    Hjortswang H, Almer S, Ström M.
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1099-104. PubMed ID: 10524638
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impact of sleep disturbances in inflammatory bowel disease.
    Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1748-53. PubMed ID: 17914945
    [Abstract] [Full Text] [Related]

  • 34. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F, López Vivancos J, Malagela JR.
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [Abstract] [Full Text] [Related]

  • 35. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark.
    Li J, Nørgard B, Precht DH, Olsen J.
    Am J Gastroenterol; 2004 Jun; 99(6):1129-33. PubMed ID: 15180736
    [Abstract] [Full Text] [Related]

  • 36. Nonpharmacologic aspects of medication.
    Barsky AJ.
    Arch Intern Med; 1983 Aug; 143(8):1544-8. PubMed ID: 6870436
    [Abstract] [Full Text] [Related]

  • 37. Psychological interactions for women with breast disease.
    Brady ML.
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):797-816. PubMed ID: 3323975
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment adherence in inflammatory bowel disease. Strategies for improvement].
    Bermejo San José F, López San Román A, García AA.
    Gastroenterol Hepatol; 2009 Oct; 32 Suppl 2():31-6. PubMed ID: 19900626
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.